Dibasic

Fosfato Dipotasico 1M Fresenius Kabi 174,2 MG/ML Solucion Inyectable

1742 mg solución inyectableSpainMarketedAuthorised 27 Dec 2000

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE , 100 ampollas de 10 ml	600215
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE , 1 ampolla de 10 ml	665794
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE 10 ampollas de 10 ml	726519

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dibasic

Fosfato Dipotasico 1M Fresenius Kabi 174,2 MG/ML Solucion Inyectable

1742 mg solución inyectableSpainMarketedAuthorised 27 Dec 2000

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE , 100 ampollas de 10 ml	600215
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE , 1 ampolla de 10 ml	665794
FOSFATO DIPOTASICO 1M FRESENIUS KABI 174,2 MG/ML SOLUCION INYECTABLE 10 ampollas de 10 ml	726519

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAEMPS

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dibasic
Strength: 1742 mg
Dosage form: solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 27 Dec 2000
Registration: 63546
Marketing authorisation holder: Fresenius Kabi España, S.A.U.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario